BR112019021858A2 - Composições para tratamento de hiperglicemia em pacientes com diabetes mellitus - Google Patents
Composições para tratamento de hiperglicemia em pacientes com diabetes mellitus Download PDFInfo
- Publication number
- BR112019021858A2 BR112019021858A2 BR112019021858-0A BR112019021858A BR112019021858A2 BR 112019021858 A2 BR112019021858 A2 BR 112019021858A2 BR 112019021858 A BR112019021858 A BR 112019021858A BR 112019021858 A2 BR112019021858 A2 BR 112019021858A2
- Authority
- BR
- Brazil
- Prior art keywords
- patients
- compositions
- diabetes mellitus
- treating hyperglycemia
- hyperglycemia
- Prior art date
Links
- 201000001421 hyperglycemia Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000004383 Steviol glycoside Substances 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229930182488 steviol glycoside Natural products 0.000 abstract 1
- 235000019411 steviol glycoside Nutrition 0.000 abstract 1
- 150000008144 steviol glycosides Chemical class 0.000 abstract 1
- 235000019202 steviosides Nutrition 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
composições compreendendo, pelo menos, um glicosídeo de esteviol são fornecidas para reduzir o nível aumentado de açúcar no sangue (hiperglicemia) em pacientes com diabetes mellitus tipo 1 e tipo 2.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762486657P | 2017-04-18 | 2017-04-18 | |
US62/486,657 | 2017-04-18 | ||
PCT/US2018/028140 WO2018195179A1 (en) | 2017-04-18 | 2018-04-18 | Compositions for treatment of hyperglycemia in diabetes mellitus patients |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112019021858A2 true BR112019021858A2 (pt) | 2020-05-26 |
Family
ID=63856877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112019021858-0A BR112019021858A2 (pt) | 2017-04-18 | 2018-04-18 | Composições para tratamento de hiperglicemia em pacientes com diabetes mellitus |
Country Status (8)
Country | Link |
---|---|
US (1) | US20200069710A1 (pt) |
EP (1) | EP3612035A4 (pt) |
CN (1) | CN110944521A (pt) |
BR (1) | BR112019021858A2 (pt) |
MX (1) | MX2019012459A (pt) |
PH (1) | PH12019550216A1 (pt) |
SG (1) | SG11201909663SA (pt) |
WO (1) | WO2018195179A1 (pt) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001279593A1 (en) * | 2001-02-01 | 2002-08-12 | Soren Gregersen | A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
EP4108668A1 (en) * | 2010-03-12 | 2022-12-28 | PureCircle USA Inc. | High-purity steviol glycosides |
WO2012082677A1 (en) * | 2010-12-13 | 2012-06-21 | Cargill, Incorporated | Glycoside blends |
CN102204611A (zh) * | 2011-03-31 | 2011-10-05 | 遵义陆圣康源科技开发有限责任公司 | 含有机高浓度茶多酚液体饮品 |
US9877501B2 (en) * | 2011-06-03 | 2018-01-30 | Purecircle Sdn Bhd | Stevia composition |
JP2014529994A (ja) * | 2011-09-15 | 2014-11-17 | シージェイ チェイルジェダング コーポレイション | 遅消化性成分を含有する糖尿改善用甘味素材組成物 |
CN103783615A (zh) * | 2014-02-21 | 2014-05-14 | 郝振东 | 一种降血糖的饮料及其制备方法 |
CN104026446B (zh) * | 2014-05-15 | 2016-08-24 | 广东省农业科学院蚕业与农产品加工研究所 | 一种适合于高血糖人群服用的营养代餐粉及其制备方法 |
CN104687176A (zh) * | 2015-02-10 | 2015-06-10 | 叶节和 | 一种植物饮料及其制备方法 |
CN106359784A (zh) * | 2016-08-30 | 2017-02-01 | 东台纳盛特生物科技有限公司 | 一种以甜菊糖苷为甜味剂的无糖巧克力及其制备方法 |
-
2018
- 2018-04-18 US US16/605,826 patent/US20200069710A1/en not_active Abandoned
- 2018-04-18 EP EP18788501.7A patent/EP3612035A4/en not_active Withdrawn
- 2018-04-18 WO PCT/US2018/028140 patent/WO2018195179A1/en unknown
- 2018-04-18 SG SG11201909663S patent/SG11201909663SA/en unknown
- 2018-04-18 MX MX2019012459A patent/MX2019012459A/es unknown
- 2018-04-18 BR BR112019021858-0A patent/BR112019021858A2/pt not_active Application Discontinuation
- 2018-04-18 CN CN201880034724.4A patent/CN110944521A/zh active Pending
-
2019
- 2019-10-18 PH PH12019550216A patent/PH12019550216A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20200069710A1 (en) | 2020-03-05 |
WO2018195179A1 (en) | 2018-10-25 |
MX2019012459A (es) | 2019-12-19 |
CN110944521A (zh) | 2020-03-31 |
EP3612035A4 (en) | 2021-01-06 |
EP3612035A1 (en) | 2020-02-26 |
SG11201909663SA (en) | 2019-11-28 |
PH12019550216A1 (en) | 2020-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017003185A1 (es) | Compuestos co-agonistas del glucagón y péptido-1 similar al glugacón (glp-1) | |
CL2018001007A1 (es) | Composiciones farmacéuticas para terapias combinadas (sol. divisional de n° 201702538). | |
PH12015502310A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
PH12015502275B1 (en) | Therapuetic uses of empagliflozin | |
ECSP13012661A (es) | Composición farmacéutica, métodos de tratamiento y usos de la misma. | |
EA201101189A1 (ru) | Ингибитор sglt-2, предназначенный для лечения сахарного диабета типа 1, сахарного диабета типа 2, нарушенной толерантности к глюкозе или гипергликемии | |
UY33700A (es) | ?combinaciones farmacéuticas para el tratamiento de trastornos metabólicos?. | |
MX2020010004A (es) | Composicion farmaceutica que comprende empagliflozina, metodos para tratamiento y sus usos. | |
AR073563A1 (es) | Terapia de combinacion para el tratamiento de diabetes y estados relacionados | |
WO2017009236A3 (en) | New exendin-4 derivatives as selective peptidic dual glp-1 / glucagon receptor agonists | |
EA201101191A1 (ru) | Фармацевтическая композиция, включающая ингибитор sglt-2, ингибитор дпп-iv и необязательно другой антидиабетический агент, и ее применение | |
UA117480C2 (uk) | Лікування цукрового діабету за допомогою складу інсуліну тривалої дії | |
CL2008003546A1 (es) | Compuestos derivados de piridina; procedimiento de preparacion; composicion farmaceutica de dichos compuestos; y uso en el tratamiento y/o profilaxis de la diabetes mellitus tipo i y/o tipo ii. | |
BR112019024859A2 (pt) | composições | |
EA201491369A1 (ru) | Способ лечения сахарного диабета при помощи негликозилированного аполипопротеина a-iv | |
MX2019014086A (es) | Compuesto de insulina acilada. | |
BR112016007487A2 (pt) | composições compreendendo citrulina e leucina e seu uso no tratamento de diabetes e de síndrome meta-bólica | |
CL2017002293A1 (es) | Tratamiento de pacientes con diabetes mellitus de tipo 2 | |
PH12017501290A1 (en) | Treatment of pediatric type 2 diabetes mellitus patients with lixisenatide | |
CO2017005383A2 (es) | Composiciones inhibidoras | |
BR112019021858A2 (pt) | Composições para tratamento de hiperglicemia em pacientes com diabetes mellitus | |
BR112018073799A2 (pt) | método de atenuação de uma resposta pós-prandial à insulina, composição edulcorante e uso de uma composição. | |
BR112022005067A2 (pt) | Fibroblastos vasculogênicos | |
WO2020018058A3 (en) | The injectable micronized human insulin | |
IT201700059292A1 (it) | Derivati 1,3-diaza-4-ossa-[3.3.1]-biciclici, loro preparazione e uso come medicinale, in particolare per il trattamento del diabete |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25G | Requested change of headquarter approved |
Owner name: PURECIRCLE USA INC. (US) |
|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |